SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of ob… […]
SAN DIEGO–(BUSINESS WIRE)–Abzena, the global partner research organization, announced it has successfully completed a technology transfer and scalability evaluation using the Synaffix technologies of GlycoConnect? (antibody conjugation) and HydraSpac… […]
Acadia Pharmaceuticals? treatment for Parkinson?s disease-related psychosis failed a Phase 3 trial that was studying use of the drug for schizophrenia patients who haven?t fully responded to existing therapies. The company announced the trial failure M… […]
Prehuman ancestors lost the ability to make a sugar molecule called a sialic acid. This led to a number of effects, both good and bad, in modern humans. The findings are contained in a study by UC San Diego scientists. […]
Carlsmed, a San Diego-based medical technology company that?s developing personalized spinal implants, has merged with Precisive Surgical, a spine imaging system startup in Seattle. The combined company, which will operate in San Diego under the Carlsm… […]
Comic-Con International may be holding everyone?s attention this week, but the tech community has stayed busy amid all the action (and increased traffic). Let?s catch up with the latest tech news in San Diego. ?San Diego?s AON Devices was among 10 star… […]
LA JOLLA?The world is filled with millions upon millions of distinct smells, but how mammals? brains evolved to tell them apart is something of a mystery.
The post How mammals? brains evolved to distinguish odors is nothing to sniff at appeared first o… […]
SAN DIEGO–(BUSINESS WIRE)–MXR The Imaging Solution Company has developed offerings into MRI, CT, and ultrasound imaging equipment and services. […]
SAN DIEGO–(BUSINESS WIRE)–#DisruptiveTechnology–CARLSMED, Inc., a San Diego-based medical technology company, and Seattle-based spine imaging company Precisive Surgical announce merger. […]
Reports + Research Trefoil Raises $28 Million for FGF-1 Treatment to Reverse Vision Loss For patients with corneal dystrophies, a cornea transplant surgery is currently the only option to prevent blindness. Trefoil Therapeutics is hoping to change that… […]
An immune system protein that usually protects the body from pathogens is abnormally produced in the brain during Parkinson?s disease, scientists from Sanford Burnham Prebys report. The discovery, published in Free Radical Biology & Medicine, indic… […]
Trefoil Therapeutics, which is developing treatments for diseases that affect the cornea, the outermost layer of the eye, has raised $28 million to move its lead drug candidate into human testing. The company is developing an engineered form of fibrobl… […]
Prestigious investors from Section 32 and Illumina Ventures have backed Cradle Genomics, a startup developing prenatal tests […]
Another company headed by former Illumina executives has launched, fueled with a $17 million Series A round from investors including a local venture capital firm. The new firm, Cradle Genomics, is seeking to commercialize improved non-invasive prenatal… […]
Texas VC Bios Partners has found a new early-stage play to love out of San Diego, leading a $28 million Series A to help Trefoil Therapeutics make the leap to the clinic.
Stella Robertson Bios Partners
Stella Robertson, who headed R&D at Novartis? … […]
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay Area in 2014, Illumina Accelerator is a company creation engine focuse… […]
Three venture capital firms were the most active in San Diego during the second quarter of 2019 […]
LA JOLLA, Calif., July 15, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today reported financial resu… […]
Organoids symposium meets in San Diego in late August […]
Biotech giant loses $8 billion in market value […]
LA JOLLA, Calif., July 11, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced its plans for a … […]
SAN DIEGO, July 11, 2019 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (NASDAQ: CYTX) ?the Company? will provide a live webcast to discuss its new company direction following two recent asset sales and highlight key anticipated milestones on July 15,… […]
American Chemical Society (ACS) National Meetings are where chemistry professionals meet to share ideas and advance scientific and technical knowledge. By attracting thousands of chemical professionals, the meeting provides excellent opportunities for … […]
If you look closely at Thursday?s bad news from Illumina, the multibillion-dollar standard-bearer of the genomics industry, you might see a worrisome sign for the consumer genetics industry. […]
Gene that controls how deep roots grow could be used in Salk Institute climate initiative, making crops hardier […]
The worldwide demand for seafood is rising while the supply of fish is diminishing. BlueNalu is working to close that gap through cellular aquaculture – manufacturing fish meat in bioreactors. It begins with a fish […]